TrialCancer immunology, immunotherapy : CII2016

Phase I/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells in patients with glioblastoma.

Yasuharu Akasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.